Literature DB >> 19519489

Interactive text mining with Pipeline Pilot: a bibliographic web-based tool for PubMed.

S G P Vellay1, N E Miller Latimer, G Paillard.   

Abstract

Text mining has become an integral part of all research in the medical field. Many text analysis software platforms support particular use cases and only those. We show an example of a bibliographic tool that can be used to support virtually any use case in an agile manner. Here we focus on a Pipeline Pilot web-based application that interactively analyzes and reports on PubMed search results. This will be of interest to any scientist to help identify the most relevant papers in a topical area more quickly and to evaluate the results of query refinement. Links with Entrez databases help both the biologist and the chemist alike. We illustrate this application with Leishmaniasis, a neglected tropical disease, as a case study.

Entities:  

Mesh:

Year:  2009        PMID: 19519489     DOI: 10.2174/1871526510909030366

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  4 in total

1.  New opportunities to fight against infectious diseases and to identify pertinent drug targets with novel methodologies.

Authors:  Alexandre G de Brevern
Journal:  Infect Disord Drug Targets       Date:  2009-06

Review 2.  Informatics Support for Basic Research in Biomedicine.

Authors:  Thomas C Rindflesch; Catherine L Blake; Marcelo Fiszman; Halil Kilicoglu; Graciela Rosemblat; Jodi Schneider; Caroline J Zeiss
Journal:  ILAR J       Date:  2017-07-01

3.  Gene List significance at-a-glance with GeneValorization.

Authors:  Bryan Brancotte; Anne Biton; Isabelle Bernard-Pierrot; François Radvanyi; Fabien Reyal; Sarah Cohen-Boulakia
Journal:  Bioinformatics       Date:  2011-02-23       Impact factor: 6.937

4.  Using workflows to explore and optimise named entity recognition for chemistry.

Authors:  Balakrishna Kolluru; Lezan Hawizy; Peter Murray-Rust; Junichi Tsujii; Sophia Ananiadou
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.